MB, Levis & Associates’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $208K | Buy |
8,573
+141
| +2% | +$3.42K | 0.09% | 68 |
|
|
2025
Q1 | $214K | Buy |
8,432
+3,647
| +76% | +$92.4K | 0.1% | 66 |
|
|
2024
Q4 | $127K | Sell |
4,785
-7,619
| -61% | -$202K | 0.06% | 75 |
|
|
2024
Q3 | $359K | Buy |
12,404
+166
| +1% | +$4.8K | 0.18% | 48 |
|
|
2024
Q2 | $342K | Buy |
12,238
+1,899
| +18% | +$53.1K | 0.18% | 49 |
|
|
2024
Q1 | $287K | Buy |
10,339
+4,971
| +93% | +$138K | 0.15% | 54 |
|
|
2023
Q4 | $155K | Sell |
5,368
-1,920
| -26% | -$55.3K | 0.09% | 62 |
|
|
2023
Q3 | $242K | Sell |
7,288
-502
| -6% | -$16.7K | 0.16% | 55 |
|
|
2023
Q2 | $286K | Buy |
7,790
+57
| +0.7% | +$2.09K | 0.18% | 53 |
|
|
2023
Q1 | $316K | Buy |
7,733
+43
| +0.6% | +$1.76K | 0.22% | 48 |
|
|
2022
Q4 | $394K | Buy |
+7,690
| New | +$394K | 0.31% | 39 |
|